The school run is where a lot of parents first notice it. A child who was fine at breakfast is suddenly rigid at the front door, or melting down over a sock seam that didn't bother him yesterday. Some of that is autism. A lot of it, often, is anxiety on top.
Anxiety and autism overlap so much that it's hard to tell where one ends and the other starts. Parents who land on our site usually have a practical question: is there a supplement that takes the edge off, and where does it sit next to everything else?
Before the detail, the short version. The intervention with the best evidence for anxiety in autistic children is a talking therapy, not a capsule. The supplement trials that exist ran mostly in adults, mostly on one ingredient at a time, and two of the popular calming ingredients carry real problems for this group. That doesn't make supplements pointless. It moves them down the running order.
How common anxiety is, and why it hides
Estimates depend on who you count and how you ask. A meta-analysis of 31 studies covering 2,121 autistic children and teenagers found about 40% met the criteria for at least one anxiety disorder, most often specific phobia, then OCD, then social anxiety (van Steensel 2011, PMID 21735077). That figure leans on clinic samples, where anxious children are over-represented. A broader review that also pulled in population and registry data landed lower, pooling anxiety disorders at around 20% across the whole autistic population (Lai 2019, PMID 31447415). So the honest range is roughly one in five to two in five, climbing toward the top in children referred to a clinic.
Either way it's well above the non-autistic rate, and it often doesn't look like worry. In an autistic child, anxiety can surface as a harder push for sameness, distress when a routine changes, a meltdown that reads as sensory, or stomach aches with no clear cause. A teenager may go quiet and pull away rather than say they're scared. That camouflage is part of why it gets missed, and why your read on your own child matters to a clinician.
Why the first move is therapy, not a supplement
For anxiety in autistic young people, the treatment with real trial support is cognitive behavioural therapy, adapted for autistic children. A randomized trial of CBT built for autistic children improved anxiety more than the comparison condition (Wood 2020, PMID 31755906), and a systematic review of anxiety treatments in this group rated CBT as the option with moderate, replicated evidence (Vasa 2014, PMID 25070468). Where anxiety is severe, clinicians also prescribe SSRIs, which are common in this population (Williams 2013, PMID 23959778).
That last point shapes everything downstream. Many autistic children who struggle with anxiety are already on a serotonin-raising medication, and that one fact rules some popular supplements out. Supplements here are adjuncts: something you add around therapy and, where a doctor has prescribed it, medication, not a stand-in for either. Nobody should stop a prescription to try a capsule.
L-theanine has the best mix of evidence and safety, and the biggest dose gap
L-theanine, an amino acid in green tea, is the calming ingredient here with the cleanest record. In a four-week crossover trial, healthy adults taking 200 mg a day scored lower on trait anxiety and slept better than on placebo (Hidese 2019, PMID 31623400), and a systematic review of the human trials came out broadly in its favour (Williams 2020, PMID 31758301). It doesn't sedate, so it can be taken in the daytime.
It's also the only one here with a positive pediatric trial, and there's a catch in that sentence. The trial was in boys with ADHD, the dose was 400 mg a day, and what it improved was sleep, not anxiety (Lyon 2011, PMID 22214254). So the child evidence is real but off-target. The bigger snag is dose: the adult trials that worked used around 200 mg a day, and reaching that cleanly in a daytime product a child can use is hard. That gap shows up in our own catalog, below.
Ashwagandha helps stressed adults, with a liver and thyroid caveat
Ashwagandha carries the largest numbers on paper. A meta-analysis of 12 randomized trials in adults found a large pooled reduction in anxiety scores (a standardized mean difference of about 1.55), and in a separate 60-day trial, adults under chronic stress had roughly 28% lower cortisol than placebo (Akhgarjand 2022, PMID 36017529; Chandrasekhar 2012, PMID 23439798). On effect size alone, it looks like the standout.
The fine print pulls it back. The meta-analysis rated its own certainty as low, because the trials disagreed with each other a lot. Every one ran in adults; there's no trial of ashwagandha for anxiety in children. And a safety signal sits underneath it: case series have tied ashwagandha to liver injury (Björnsson 2020, PMID 31991029), and it can push thyroid hormones up, a problem for anyone with thyroid disease or on thyroid medication. It's defensible for a stressed adult who has cleared it with their doctor, and wrong for a child, in pregnancy, or with a liver or thyroid condition.
Magnesium, omega-3 and oral GABA are weaker bets, and dose decides them
These three get grouped for calm support, and the evidence thins out fast. For magnesium, a systematic review found a suggestive benefit on self-reported anxiety, but the studies were poor quality and the effect showed up mainly in people already stressed or already low on magnesium (Boyle 2017, PMID 28445426). Magnesium is cheap and well tolerated at sensible doses, a reasonable foundation, not a treatment.
Omega-3 is a dose story. Pooling 19 trials, researchers found a small overall reduction in anxiety symptoms (a Hedges g of about 0.37), but the benefit concentrated in studies using at least 2,000 mg a day of EPA plus DHA, and in people with a diagnosed condition rather than the general public (Su 2018, PMID 30646157). That's higher than most everyday fish-oil routines reach, which matters for our own doses.
Oral GABA is the weakest of the set. A systematic review called the human evidence for stress limited, and thinner still for sleep (Hepsomali 2020, PMID 33041752), and an older, unresolved question hangs over the idea: whether GABA you swallow reaches the brain in any meaningful amount (Boonstra 2015, PMID 26500584). The likeliest story is that it acts on nerves in the gut, not the brain. We keep it as a mild, optional pick, honest about how slim the support is.
Why we leave 5-HTP out of the calming lineup
5-HTP turns up in a lot of calm and sleep blends, and the logic looks tidy: the body uses it to make serotonin. Two problems keep it out of what we suggest for these children. First, the controlled-trial evidence for 5-HTP sits in depression, not anxiety, and even there a Cochrane review judged it too weak to lean on (Shaw 2002, PMID 11869656). Second, and this is the deciding one, 5-HTP raises serotonin, and so do the SSRIs many of these children already take. Stacking two serotonin-raising agents risks serotonin syndrome, a real medical emergency (Turner 2006, PMID 16023217).
For this audience the risk isn't hypothetical. The caution exists for exactly this situation: a child on an antidepressant whose parent adds a serotonin-raising supplement on top. So any product carrying 5-HTP, ours or anyone else's, is one to keep away from a child on an antidepressant unless the prescriber has signed off. It's the clearest case here of a popular ingredient being a poor fit for the very people reaching for it.
How this shapes our protocol
Our Calm Support protocol follows that running order. For adults, the core is Calming Cortisol, which pairs ashwagandha with L-theanine, on top of our Daily Base of Omega-3 Mini, Vitamin D3 Micellized and Magnesium Night. Taken as directed, it gives about 200 mg of L-theanine a day, the adult-trial dose, plus ashwagandha inside the studied range. For anyone who should skip ashwagandha, in pregnancy, with a thyroid or liver concern, or wanting the gentlest option, GABA Lozenges are the no-ashwagandha alternative, and we say plainly that the GABA evidence is thin.
For children, the core is the GABA CoFactors Spray Tonic plus the child Daily Base, used with a practitioner, not lifted off a shelf. It's built around L-theanine, the ingredient with a pediatric trial behind it, and leaves out 5-HTP, lithium and ashwagandha on purpose. The honest part: a serving gives about 30 mg of L-theanine, well below the roughly 200 mg used in the trials. It's support before or during a hard moment, not a therapeutic dose, and we'd rather say so than dress it up.
A few limits cover the whole protocol. Almost every positive trial behind these ingredients ran in adults, on one ingredient at a time; no supplement here has a randomized trial showing it reduces anxiety in autistic children, and no bundle has been tested as a whole. Some product doses fall short of the trial doses on purpose: the child theanine because of age, and the omega-3 because the anxiety-level dose (around 2,000 mg a day) is far more fish oil than a daily foundation carries. All of it sits behind therapy, not in front of it. You can see what's in the protocol and how we sequence it on the Calm Support protocol page.
Sources
- van Steensel FJA, Bögels SM, Perrin S. Anxiety disorders in children and adolescents with autistic spectrum disorders: a meta-analysis. Clin Child Fam Psychol Rev, 2011. PMID 21735077.
- Lai MC, et al. Prevalence of co-occurring mental health diagnoses in the autism population: a systematic review and meta-analysis. Lancet Psychiatry, 2019. PMID 31447415.
- Wood JJ, et al. Cognitive behavioural therapy for anxiety in children with autism spectrum disorder: a randomized controlled trial. JAMA Psychiatry, 2020. PMID 31755906.
- Vasa RA, et al. A systematic review of treatments for anxiety in youth with autism spectrum disorders. J Autism Dev Disord, 2014. PMID 25070468.
- Williams K, et al. Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders. Cochrane Database Syst Rev, 2013. PMID 23959778.
- Hidese S, et al. Effects of L-theanine on stress-related symptoms and cognition in healthy adults: a randomized controlled trial. Nutrients, 2019. PMID 31623400.
- Williams JL, et al. L-theanine and stress and anxiety: a systematic review. Plant Foods Hum Nutr, 2020. PMID 31758301.
- Lyon MR, et al. L-theanine (Suntheanine) and sleep quality in boys with ADHD: a randomized controlled trial. Altern Med Rev, 2011. PMID 22214254.
- Akhgarjand C, et al. Ashwagandha for anxiety and stress: a systematic review and meta-analysis. Phytother Res, 2022. PMID 36017529.
- Chandrasekhar K, et al. A standardized ashwagandha root extract for stress and anxiety in adults: a randomized controlled trial. Indian J Psychol Med, 2012. PMID 23439798.
- Björnsson HK, et al. Ashwagandha-induced liver injury: a DILIN case series. Liver Int, 2020. PMID 31991029.
- Boyle NB, Lawton C, Dye L. Magnesium supplementation and subjective anxiety and stress: a systematic review. Nutrients, 2017. PMID 28445426.
- Su KP, et al. Omega-3 polyunsaturated fatty acids and anxiety symptoms: a systematic review and meta-analysis. JAMA Netw Open, 2018. PMID 30646157.
- Hepsomali P, et al. Oral GABA and stress and sleep in humans: a systematic review. Front Neurosci, 2020. PMID 33041752.
- Boonstra E, et al. Neurotransmitters as food supplements: GABA and brain and behaviour. Front Psychol, 2015. PMID 26500584.
- Shaw K, Turner J, Del Mar C. Tryptophan and 5-hydroxytryptophan for depression. Cochrane Database Syst Rev, 2002. PMID 11869656.
- Turner EH, et al. Serotonin à la carte: supplementation with the serotonin precursor 5-hydroxytryptophan. Pharmacol Ther, 2006. PMID 16023217.
These statements have not been evaluated by the Food and Drug Administration. Our supplements are dietary supplements and are not intended to diagnose, treat, cure or prevent any disease. This article is educational and is not medical advice.